Business
QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio
QuidelOrtho has entered a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. (Lifotronic Technology Co., Ltd., stock code: 688389), to expand QuidelOrtho's global immunoassay portfolio and accelerate customer access to scalable, high quality, cost-efficient solutions across select markets outside the United States.
About this update from Quidelortho Corporation
[{"type":"text","content":"Agreement adds new analyzer platforms and expands assay menu across key international markets","length":93,"tagName":"p","attribs":{}},{"type":"text","content":"SAN DIEGO, Feb. 16, 2026 /PRNewswire/ -- QuidelOrtho has entered a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. (Lifotronic Technology Co., Ltd., stock code: 688389), to expand QuidelOrtho's global immunoassay portfolio and accelerate customer access to scalable, high quality, cost-efficient solutions across select markets outside the United States.","length":384,"tagName":"p"},{"type":"image","alt":"Lifotronic and Q ","displaySize":"","headline":null,"caption":"Lifotronic and Q ","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":267,"url":"https://media.zenfs.com/en/prnewswire.com/2d674ded1c3ae70fc59a0f9a91b1e94b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/m2gs8MHLSpiJxUKqxXN7yA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ3MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/2d674ded1c3ae70fc59a0f9a91b1e94b","width":400,"height":267}}},{"type":"text","content":"The agreement provides QuidelOrtho access to multiple high-throughput and low-to-mid volume immunoassay analyzer platforms, each supported by a broad menu of assays spanning routine and specialty testing. The collaboration is expected to expand QuidelOrtho's immunoassay menu with more than 25 new assays on these systems that are not currently available on the VITROS system, within a total menu of over 70 assays on these new partner platforms.","length":450,"tagName":"p"},{"type":"text","content":"These additions are planned to increase QuidelOrtho's ability to compete for full-menu tenders and serve a wider range of laboratory settings, from smaller laboratories seeking low-volume solutions to larger, high-throughput environments that require scalable capacity and broad test menus.","length":294,"tagName":"p"},{"type":"text","content":"Bryan Hanson, Senior Vice President of Global Clinical Laboratory and Transfusion Medicine at QuidelOrtho, said:"Through our collaboration with Lifotronic Technology, QuidelOrtho will rapidly introduce scalable testing solutions that further advance our long-term innovation strategy in core growth markets. This agreement strengthens our portfolio in markets where assay breadth and cost efficiency a...